BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34706602)

  • 21. Detection of NRG1 Gene Fusions in Solid Tumors.
    Jonna S; Feldman RA; Swensen J; Gatalica Z; Korn WM; Borghaei H; Ma PC; Nieva JJ; Spira AI; Vanderwalde AM; Wozniak AJ; Kim ES; Liu SV
    Clin Cancer Res; 2019 Aug; 25(16):4966-4972. PubMed ID: 30988082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plain language summary of NRG1 fusions in cancer: current knowledge and treatment with afatinib and other drugs.
    Liu SV
    Future Oncol; 2022 Aug; 18(26):2865-2870. PubMed ID: 35876504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD74-NRG1 fusions in lung adenocarcinoma.
    Fernandez-Cuesta L; Plenker D; Osada H; Sun R; Menon R; Leenders F; Ortiz-Cuaran S; Peifer M; Bos M; Daßler J; Malchers F; Schöttle J; Vogel W; Dahmen I; Koker M; Ullrich RT; Wright GM; Russell PA; Wainer Z; Solomon B; Brambilla E; Nagy-Mignotte H; Moro-Sibilot D; Brambilla CG; Lantuejoul S; Altmüller J; Becker C; Nürnberg P; Heuckmann JM; Stoelben E; Petersen I; Clement JH; Sänger J; Muscarella LA; la Torre A; Fazio VM; Lahortiga I; Perera T; Ogata S; Parade M; Brehmer D; Vingron M; Heukamp LC; Buettner R; Zander T; Wolf J; Perner S; Ansén S; Haas SA; Yatabe Y; Thomas RK
    Cancer Discov; 2014 Apr; 4(4):415-22. PubMed ID: 24469108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Similarities between Neuregulin 1-3 Isoforms Determine Their Subcellular Distribution and Signaling Mode in Central Neurons.
    Vullhorst D; Ahmad T; Karavanova I; Keating C; Buonanno A
    J Neurosci; 2017 May; 37(21):5232-5249. PubMed ID: 28432142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Novel
    Ou SI; Xiu J; Nagasaka M; Xia B; Zhang SS; Zhang Q; Swensen JJ; Spetzler D; Korn WM; Zhu VW; Liu SV
    JTO Clin Res Rep; 2021 Feb; 2(2):100132. PubMed ID: 34589990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
    Ptáková N; Martínek P; Holubec L; Janovský V; Vančurová J; Grossmann P; Navarro PA; Rodriguez Moreno JF; Alaghehbandan R; Hes O; Májek O; Pešek M; Michal M; Ondič O
    Genes Chromosomes Cancer; 2021 Jul; 60(7):474-481. PubMed ID: 33583086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NRG1 fusions: Biology to therapy.
    Liu SV
    Lung Cancer; 2021 Aug; 158():25-28. PubMed ID: 34098222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy.
    Chen K; Li W; Xi X; Zhong J
    Thorac Cancer; 2022 Nov; 13(21):3063-3067. PubMed ID: 36096509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
    Severson E; Achyut BR; Nesline M; Pabla S; Previs RA; Kannan G; Chenn A; Zhang S; Klein R; Conroy J; Sausen M; Sathyan P; Saini KS; Ghosh A; Jensen TJ; Reddy P; Ramkissoon SH
    J Mol Diagn; 2023 Jul; 25(7):454-466. PubMed ID: 37164276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer.
    Jones MR; Lim H; Shen Y; Pleasance E; Ch'ng C; Reisle C; Leelakumari S; Zhao C; Yip S; Ho J; Zhong E; Ng T; Ionescu D; Schaeffer DF; Mungall AJ; Mungall KL; Zhao Y; Moore RA; Ma Y; Chia S; Ho C; Renouf DJ; Gelmon K; Jones SJM; Marra MA; Laskin J
    Ann Oncol; 2017 Dec; 28(12):3092-3097. PubMed ID: 28950338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy.
    Ondič O; Ptáková N; Janovský V; Vančurová J; Hósová M; Michal M; Pešek M
    Klin Onkol; 2022; 35(4):271-275. PubMed ID: 35989083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma.
    Duruisseaux M; McLeer-Florin A; Antoine M; Alavizadeh S; Poulot V; Lacave R; Rabbe N; Cadranel J; Wislez M
    Cancer Med; 2016 Dec; 5(12):3579-3585. PubMed ID: 27770508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of NRG1 Gene Fusions in a Large Population of Chinese Patients with NSCLC.
    Ke H; Shen W; Hu A; Ou Q; Lu S
    J Thorac Oncol; 2019 Dec; 14(12):e263-e266. PubMed ID: 31757375
    [No Abstract]   [Full Text] [Related]  

  • 34. Frequent
    Trombetta D; Graziano P; Scarpa A; Sparaneo A; Rossi G; Rossi A; Di Maio M; Antonello D; Mafficini A; Fabrizio FP; Manzorra MC; Balsamo T; Centra F; Simbolo M; Pantalone A; Notarangelo M; Parente P; Lucia Dimitri MC; Bonfitto A; Fiordelisi F; Storlazzi CT; L'Abbate A; Taurchini M; Maiello E; Fazio VM; Muscarella LA
    Oncotarget; 2018 Feb; 9(11):9661-9671. PubMed ID: 29515761
    [No Abstract]   [Full Text] [Related]  

  • 35.
    Jones MR; Williamson LM; Topham JT; Lee MKC; Goytain A; Ho J; Denroche RE; Jang G; Pleasance E; Shen Y; Karasinska JM; McGhie JP; Gill S; Lim HJ; Moore MJ; Wong HL; Ng T; Yip S; Zhang W; Sadeghi S; Reisle C; Mungall AJ; Mungall KL; Moore RA; Ma Y; Knox JJ; Gallinger S; Laskin J; Marra MA; Schaeffer DF; Jones SJM; Renouf DJ
    Clin Cancer Res; 2019 Aug; 25(15):4674-4681. PubMed ID: 31068372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
    Schram AM; Odintsov I; Espinosa-Cotton M; Khodos I; Sisso WJ; Mattar MS; Lui AJW; Vojnic M; Shameem SH; Chauhan T; Torrisi J; Ford J; O'Connor MN; Geuijen CAW; Schackmann RCJ; Lammerts van Bueren JJ; Wasserman E; de Stanchina E; O'Reilly EM; Ladanyi M; Drilon A; Somwar R
    Cancer Discov; 2022 May; 12(5):1233-1247. PubMed ID: 35135829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuregulin-1-mediated ErbB2-ErbB3 signalling protects human trophoblasts against apoptosis to preserve differentiation.
    Fock V; Plessl K; Draxler P; Otti GR; Fiala C; Knöfler M; Pollheimer J
    J Cell Sci; 2015 Dec; 128(23):4306-16. PubMed ID: 26490994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.
    Ieguchi K; Fujita M; Ma Z; Davari P; Taniguchi Y; Sekiguchi K; Wang B; Takada YK; Takada Y
    J Biol Chem; 2010 Oct; 285(41):31388-98. PubMed ID: 20682778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTAK/neuregulin-2 secreted by astrocytes promotes survival and neurite outgrowth of neurons via ErbB3.
    Nakano N; Kanekiyo K; Nakagawa T; Asahi M; Ide C
    Neurosci Lett; 2016 May; 622():88-94. PubMed ID: 27113200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plain language summary of publication: new information for the potential role of afatinib in treating people with
    Cadranel J
    Future Oncol; 2022 Jun; 18(18):2193-2200. PubMed ID: 35400204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.